ArticlePLoS computational biology2025
Federated learning for COVID-19 mortality prediction in a multicentric sample of 21 hospitals.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evidence-Guided Multimodal Risk Prediction Framework for Severe COVID-19 Outcomes Using EHR and CT Imaging for COVID-19 Clinical Decision Support.Bioengineering (Basel, Switzerland) · 2026Article
- Multi-scenario evaluation of federated learning for privacy-preserving malaria prediction with Ghana DHS data.PLOS digital health · 2026Article
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We evaluated Federated Learning (FL) strategies for predicting COVID-19 mortality using a multicenter sample of 17,022 patients from 21 diverse Brazilian hospitals. We tested horizontal FL architectures employing Logistic Regression (LR) and a Multi-Layer Perceptron (MLP) via parameter aggregation, alongside a novel Federated Random Forest (RF) using ensemble aggregation. Performance gain (ΔAUC, calculated as AUC[Formula: see text] minus AUC[Formula: see text]) was quantified using bootstrap analysis to determine 95% confidence intervals. FL models demonstrated a beneficial collaborative effect. The average ΔAUC across the network was +0.0018 for LR, +0.0599 for MLP, and +0.0528 for RF. Crucially, the gain's magnitude and statistical significance showed a strong inverse correlation with local patient volume (N). Substantial and statistically significant gains concentrated in data-limited institutions (N < 500). For example, the smallest hospital (N=86) achieved a remarkable ΔAUC of 0.3682 (95% CI [0.0908, 0.6307]) with the RF model. However, interpreting these benefits requires caution because the 95% CIs for ΔAUC crossed zero for the majority of hospitals, suggesting the collaborative model's statistical advantage is not universally certain at every site. This trade-off was particularly evident with the MLP model which, despite achieving the highest average ΔAUC, was the most volatile algorithm, registering the maximum performance degradation in the network (ΔAUC = -0.0884, 95% CI [-0.1527, -0.0273]) due to its high sensitivity to local data distribution disparities (non-IID). This study validates FL as an equity-enabling mechanism that effectively enhances predictive capacity where local data scarcity is highest. Our findings underscore that maximizing the most statistically certain benefits of FL requires continuous monitoring and local validation for successful clinical deployment across diverse settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.